Combination of drugs for obesity and type 2 diabetes may be
Researchers are teaming up to identify new drug combinations to treat people with obesity and type 2 diabetes. The goal is to develop personalized prescriptions that are more effective than single drugs and that can potentially replace more invasive treatments such as bariatric surgery, especially for children.

The potential of several drugs that control incretins. These metabolic hormones stimulate the body to produce insulin and use it effectively. They also suppress appetite in order to control blood sugars and reduce weight. The researchers conclude that combining the drugs has several advantages, including higher effectiveness in at least some patients and fewer side-effects. Even a five percent weight loss is considered clinically meaningful, and patients in some of the combination drug trials are achieving 10 or 15 percent.